Abstract
The objective of the present investigation was to explore the formulation and evaluation of in situ gel for the nasal delivery of artemether (ARM), a poorly water-soluble antimalarial agent using temperature induced gelation technique using Pluronic with mucoadhesive polymer Hydroxy Propyl Methyl Cellulose (HPMC) K4M in different ratios. Initially, due to low water solubility, an inclusion complex of the antimalarial artemether (ARM) in hydroxypropyl-β-cyclodextrin (HPβCD) was prepared and characterized. The in situ gels so prepared were characterized for its gelation properties, viscosity, gel strength, mucoadhesion, drug content, drug release rate and for its histopathological studies. Pluronic and HPMC based in situ gel (PLH2) showed the effective gelation, viscosity, gel strength and drug release properties along with good mucoadhesive strength, it is further subjected for stability studies carried out at 30 ± 2 °C and 60 ± 5% RH for 90 days in order to know the influence of temperature and relative humidity on drug content and on drug release profile. Histological examination of formulations did not show any remarkable damage to nasal mucosa. The formulation also retained the good stability at accelerated conditions over the period of 90 days. Owing to these properties it can be used as an effective delivery system for the nasal route. These in situ gelling systems would be definitely useful for cerebral malaria.
Similar content being viewed by others
References
Balint, G.A.: Artemisinin and its derivatives: an important new class of antimalarial agents. Pharmacol. Ther. 90, 261–265 (2001)
Baker, J.K., Yarber, R.H., Hufford, C.D., Lee, I.S., Elsohly, H.N., McChesney, J.D.: Thermospray mass spectroscopy/high performance liquid chromatographic identification of the metabolites formed from arteether using a rat liver microsome preparation. Biomed. Environ. Mass. Spectrom. 18, 337–351 (1988)
Balasubramaniam, J., Kant, S., Pandit, J.K.: In vitro and in vivo evaluation of the Gelrite® gellan gum-based ocular delivery system for indomethacin. Acta Pharm. 53, 251–261 (2003)
Behl, C.R., Harper, N.J., Pei, J.Y.: A general method of accessing skin permeatin enhancement mechanisms and optimization. In: Hsies, D.S., (eds.) Drug permeation enhancement: theory and applications, 1st edn, p. 115. New York, NY: Marcel Dekker Inc (1994)
Yang, B., Lin, J., Chen, Y., Liu, Y.: Artemether/hydroxypropyl-b cyclodextrin host–guest system: characterization, phase-solubility and inclusion mode. Bioorg. Med. Chem. 17, 6311–6317 (2009)
Brewster, M.E., Loftsson, T.: The use of chemically modified cyclodextrins in the development of formulations for chemical delivery systems. Pharmazie 57, 94 (2002)
Bromberg, L.E., Ron, E.S.: Protein and peptide release from temperature responsive gels and thermogelling polymer matrices. Adv. Drug Deliv. Rev. 31, 197–221 (1998)
Castronuovo, G., Niccoli, M.: Thermodynamics of inclusion complexes of natural and modified cyclodextrins with propanolol in aqueous solution at 298 K. Bioorg. Med. Chem. 14, 3883–3887 (2006)
Davis, M.E., Brewster, M.E.: Cyclodextrin-based pharmaceutics: past, present, future. Nat. Rev. Drug Discov. 3, 1023 (2004)
Desai, J., Alexander, K., Riga, A.: Characterization of polymeric dispersions of dimenhydrinate in ethyl cellulose for controlled release. Int. J. Pharm. 308, 115–123 (2006)
Duchene, D., Wouessidjewe, D., Poncel, G.: Cyclodextrins and carrier systems. J. Control. Release 62, 263–268 (1999)
Edsman, K., Carlfors, J., Petersson, R.: Rheological evaluation of poloxamer as an in situ gel for ophthalmic use. Eur. J. Pharm. Sci. 6, 105–112 (1998)
Foley, M., Tilley, L.: Qinghaosu (artemisinin): an antimalarial drug from China. Int. J. Parasitol. 27, 213 (1997)
Graff, C.L., Pollack, G.M.: Nasal drug administration: potential for targeted central nervous system delivery. J. Pharm. Sci. 94, 1187–1195 (2005)
Greenwood, B., Mutabingwa, T.: Malaria in 2002. Nature 415, 670–672 (2002)
Gonjari, I.D., Kasture, P.V.: Temperature induced in situ mucoadhesive gel of Tramadol hydrochlioride for nasal drug delivery. J. Pharm. Res. 6(2), 89–93 (2007)
Gould, S., Scott, R.C.: 2-Hydroxypropyl-β-cyclodextrin (HP-β-CD): a toxicology review. Food Chem. Toxicol. 43, 1451 (2005)
Hien, T.T., Davis, T.M., Chuong, L.V., Ilett, K.F., Sinh, D.X., Phu, N.H., Agus, C., Chiswell, G.M., White, N.J., Farrar, J.: Comparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malaria. Antimicrob. Agents Chemother. 48, 4234–4239 (2004)
Irie, T., Uekama, K.: Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J. Pharm. Sci. 86, 147 (1997)
Jiang, X., et al.: A novel nasal delivery system of a Chinese traditional medicine, Radix Bupleuri, based on the concept of ion-activated in situ gel. Arch. Pharm. Res. 30(8), 1014–1019 (2007). http://apr.psk.or.kr
Jomaa, H., Wiesner, J., Sanderbrand, S., Altincicek, B., Weidemeyer, C., Hintz, M., Tübachova, I., Eberl, M., Zeider, J., Liechtenthaler, H.K., Soldati, D., Beck, E.: Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. Science 285, 1573 (1999)
Kiechel, J. R., Malmison, R.: Nasal compositions. US Patent: 4,885,305 (1989)
Klayman, D.: Qinghaosu (artemisinin). An antimalarial drug from China. Science 228, 1049–1055 (1989)
Loftsson, T., Brewster, M.E.: Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci. 85, 1017–1025 (1996)
Loftsson, T., Järvinen, T.: Cyclodextrins in ophthalmic drug delivery. Adv. Drug Deliv. Rev. 36, 59 (1999)
Maggs, J.L., Bishop, L.P.D., Edwards, G., O’Neill, P.M., Ward, S.A., Winstanley, P.A., Mturi, N., Musumba, C.O., Wamola, B.M., Ogutu, B.R., Newton, C.R.: Cerebral malaria: optimising management. CNS Drugs 17, 153–165 (2003)
Murthy, R. S. R., Majithiya, R. J., Ghosh P. K.: Thermoreversible-mucoadhesive gel for nasal delivery of Sumatriptan. AAPS PharmSciTech. 7(3), E1–E7 (2006). (http://www.aapspharmscitech.org)
Peppas, N.A., Bures, P., Leobandung, W., Ichikawa, H.: Hydrogels in pharmaceutical formulations. Eur. J. Pharm. Biopharm. 50, 27–46 (2000)
Ruel-Gariepy, E., Leroux, J.C.: In situ forming hydrogels—review of temperature- sensitive systems. Eur. J. Pharm. Biopharm. 58, 409–426 (2004)
Shrivastava A., Nagori B.P., Saini P, Issarani R., Gaur S.S.: New simple and economical spectrophotometric method for estimation of artemether in pharmaceutical dosage forms. Asian J. Res. Chem. 1, 19–21 (2008)
Tu¨rker, S., Onur, E., O¨ zur, Y.: Nasal route and drug delivery systems. Pharm. World Sci. 26, 137–142 (2004)
Uekama, K., Hirayama, F., Irie, T.: Cyclodextrin drug carrier systems. Chem. Rev. 98, 2045 (1998)
Yong, C.S., Choi, J.S., Rhee, J.D.: Effect of sodium chloride on the gelation temperature, gel strength, and bioadhesive force of poloxamer gels containing diclofenac sodium. Int. J. Pharm. 226, 195–205 (2001)
Acknowledgement
The authors are thankful to Macleod Pharmaceutical Ltd., Daman for generous gift of artemether drug sample.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mahajan, H.S., Shah, S.K. & Surana, S.J. Nasal in situ gel containing hydroxy propyl β-cyclodextrin inclusion complex of artemether: development and in vitro evaluation. J Incl Phenom Macrocycl Chem 70, 49–58 (2011). https://doi.org/10.1007/s10847-010-9861-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10847-010-9861-x